Literature DB >> 1618163

Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion.

G Martinez de la Escalera1, R I Weiner.   

Abstract

We have reviewed the literature, which supports an important role for dopamine withdrawal in the regulation of PRL secretion. Concentrations of dopamine in the hypophyseal portal circulation are sufficient to occupy the majority of dopamine receptors (1) and tonically suppress PRL secretion (20-26). Brief escapes from dopaminergic regulation associated with the secretion of PRL have been observed (37-41). Therefore, dopamine regulates secretion of PRL both by occupancy of, as well as dissociation from, specific D2 dopamine receptors. The rapid off rate from its receptor (2) is consistent with signals transmitted through brief decreases in dopamine concentration. The removal of dopamine for 10 min results in increases in intracellular cAMP and presumably activation of protein kinase A (39, 138) as well as activation of phospholipase C (137, 138) and protein kinase C (136). The removal of dopamine results directly in the release of PRL (37-41). Furthermore, the brief removal of dopamine results in the long-term potentiation of the PRL-releasing action of TRH (38-40). The potentiating action of dopamine withdrawal appears to be mediated by the activation of protein kinase A since pretreatment with VIP, a hormone that signals via protein kinase A, also potentiates the action of TRH (39). TRH stimulates PRL release via Ca2+/protein kinase C (177-184). The potentiating action of dopamine removal is selective for the Ca2+/protein kinase C pathway since dopamine removal does not potentiate the PRL-secreting action of VIP (38, 87, 92). The action of TRH is potentiated up to 30 min after the return of dopamine and the suppression of PRL to basal levels (38). In Fig. 10, dopamine dissociation from its receptor or VIP association to its receptor are shown separated by a broken line to indicate that by the time the potentiation of the action of TRH is tested, either dopamine is again occupying its receptor or VIP is no longer present. Therefore, the effect of protein kinase A activation is remembered by the lactotroph. We hypothesize that the responsiveness of the cell to TRH is potentiated by the phosphorylation of proteins by protein kinase A. Two potential substrates for protein kinase A are voltage-dependent Ca2+ channels and protein phosphatase inhibitors that would prolong the action of protein kinase C. When TRH occupies its receptor, intracellular Ca2+ levels are increased first from intracellular stores and subsequently by extracellular Ca2+ influx (187-189). Intracellular Ca2+ is mobilized by increased levels of IP3(128). Extracellular Ca2+ enters the lactotroph via voltage-dependent Ca2+ channels (189, 190).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618163     DOI: 10.1210/edrv-13-2-241

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  11 in total

1.  In vitro, nitric oxide (NO) stimulates LH secretion and partially prevents the inhibitory effect of dopamine on PRL release.

Authors:  D González; E Aguilar
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

Review 2.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 3.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

4.  Variations in the response of pituitary lactotrophs to oxytocin during the rat estrous cycle.

Authors:  Joël Tabak; Arturo E Gonzalez-Iglesias; Natalia Toporikova; Richard Bertram; Marc E Freeman
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

5.  Inhibition of prolactin secretion from the male rat anterior pituitary by cryptic sequences of prothyrotropin releasing hormone, ProTRH178-199 and ProTRH186-199.

Authors:  Thomas H Alexander; Robert J Handa; Robert F McGivern
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 6.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

7.  Galanin positively modulates prolactin secretion in normal women.

Authors:  S Grottoli; E Arvat; L Gianotti; J Ramunni; L Di Vito; B Maccagno; E Ciccarelli; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

8.  Functional expression of the dopamine-activated K(+) current in lactotrophs during the estrous cycle in female rats: correlation with prolactin secretory responses.

Authors:  Karen A Gregerson
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 9.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

Review 10.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.